Biomarker analysis in diabetic macular oedema: Baseline and one-year follow-up characteristics in real clinical practice
- Advances in Ophthalmology & Visual System
-
Barrera Arshavin P,<sup>1</sup> Quezada Peralta G,<sup>2</sup> Abreu González R,<sup>3</sup> Perez Gonzalez M<sup>4</sup>
PDF Full Text
Abstract
Objective: To describe the baseline characteristics of patients with diabetic macular
oedema (DMO), both clinical and OCT biomarkers using AI and compare them at one-year
follow-up.
Methods: A descriptive cross-sectional and retrospective study was carried out on diabetic
patients with a new diagnosis of DME and naive to treatment who consecutively attended
our center over a period of two years. These patients were followed up during the year
following their inclusion.
Results: The study included 72 patients diagnosed with DME. No significant differences
were found in age, visual acuity (VA) and glycosylated hemoglobin between sexes, except
for dyslipidemia, which was more prevalent in men. At one year follow-up, there was a
significant reduction in intraretinal fluid (IRF), but not in subretinal fluid (SRF) or pigment
epithelial detachment (PED). In addition, there was a significant increase in the prevalence
of epiretinal membrane (ERM) and geographic atrophy (GA).
Conclusion: The study highlights a significant reduction of intraretinal fluid in patients
with DME after one year of follow-up, but also an increase in the prevalence of epiretinal
membrane and geographic atrophy. These results emphasize the importance of using
advanced tools such as OCT with AI for better assessment and prognosis of DME in real
clinical practice.
Keywords
diabetic macular oedema, tomographic biomarkers, artificial intelligence in ophthalmology